Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Utilization of proton therapy: evidence-based, market-driven, or something in-between?

Dvorak T, Fitzek MM, Wazer DE.

Am J Clin Oncol. 2013 Apr;36(2):192-6. doi: 10.1097/COC.0b013e3182438d92.

PMID:
22391432
2.

Proton therapy.

McDonald MW, Fitzek MM.

Curr Probl Cancer. 2010 Jul-Aug;34(4):257-96. doi: 10.1016/j.currproblcancer.2010.04.008. No abstract available.

PMID:
20647112
3.

Water equivalent thickness values of materials used in beams of protons, helium, carbon and iron ions.

Zhang R, Taddei PJ, Fitzek MM, Newhauser WD.

Phys Med Biol. 2010 May 7;55(9):2481-93. doi: 10.1088/0031-9155/55/9/004. Epub 2010 Apr 6.

4.

G2-phase chromosomal radiosensitivity of primary fibroblasts from hereditary retinoblastoma family members and some apparently normal controls.

Wilson PF, Nagasawa H, Fitzek MM, Little JB, Bedford JS.

Radiat Res. 2010 Jan;173(1):62-70. doi: 10.1667/RR1943.1.

5.

Retreatment of trigeminal neuralgia with Gamma Knife radiosurgery: is there an appropriate cumulative dose? Clinical article.

Dvorak T, Finn A, Price LL, Mignano JE, Fitzek MM, Wu JK, Yao KC.

J Neurosurg. 2009 Aug;111(2):359-64. doi: 10.3171/2008.11.JNS08770. Review.

PMID:
19326978
6.

Perineural invasion of cutaneous squamous cell carcinoma and basal cell carcinoma: raising awareness and optimizing management.

Geist DE, Garcia-Moliner M, Fitzek MM, Cho H, Rogers GS.

Dermatol Surg. 2008 Dec;34(12):1642-51. doi: 10.1111/j.1524-4725.2008.34341.x. Epub 2008 Oct 13.

PMID:
19018830
7.
8.

Dosimetric impact of tantalum markers used in the treatment of uveal melanoma with proton beam therapy.

Newhauser WD, Koch NC, Fontenot JD, Rosenthal SJ, S Gombos D, Fitzek MM, Mohan R.

Phys Med Biol. 2007 Jul 7;52(13):3979-90. Epub 2007 Jun 6.

PMID:
17664589
9.

A defect in DNA double strand break processing in cells from unaffected parents of retinoblastoma patients and other apparently normal humans.

Kato TA, Wilson PF, Nagasawa H, Fitzek MM, Weil MM, Little JB, Bedford JS.

DNA Repair (Amst). 2007 Jun 1;6(6):818-29. Epub 2007 Mar 6.

PMID:
17339135
10.

Visual outcome of accelerated fractionated radiation for advanced sinonasal malignancies employing photons/protons.

Weber DC, Chan AW, Lessell S, McIntyre JF, Goldberg SI, Bussiere MR, Fitzek MM, Thornton AF, Delaney TF.

Radiother Oncol. 2006 Dec;81(3):243-9. Epub 2006 Oct 16.

PMID:
17050017
11.

Abnormal gene expression profiles in unaffected parents of patients with hereditary-type retinoblastoma.

Chuang EY, Chen X, Tsai MH, Yan H, Li CY, Mitchell JB, Nagasawa H, Wilson PF, Peng Y, Fitzek MM, Bedford JS, Little JB.

Cancer Res. 2006 Apr 1;66(7):3428-33.

12.
13.

Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].

Lev MH, Ozsunar Y, Henson JW, Rasheed AA, Barest GD, Harsh GR 4th, Fitzek MM, Chiocca EA, Rabinov JD, Csavoy AN, Rosen BR, Hochberg FH, Schaefer PW, Gonzalez RG.

AJNR Am J Neuroradiol. 2004 Feb;25(2):214-21. Erratum in: AJNR Am J Neuroradiol. 2004 Mar;25(3):B1.

14.

Neuroendocrine tumors of the sinonasal tract. Results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy.

Fitzek MM, Thornton AF, Varvares M, Ancukiewicz M, Mcintyre J, Adams J, Rosenthal S, Joseph M, Amrein P.

Cancer. 2002 May 15;94(10):2623-34.

15.

Unexpected sensitivity to radiation of fibroblasts from unaffected parents of children with hereditary retinoblastoma.

Fitzek MM, Dahlberg WK, Nagasawa H, Mukai S, Munzenrider JE, Little JB.

Int J Cancer. 2002 Jun 10;99(5):764-8.

16.

Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: results of an institutional phase I/II trial.

Fitzek MM, Thornton AF, Harsh G 4th, Rabinov JD, Munzenrider JE, Lev M, Ancukiewicz M, Bussiere M, Hedley-Whyte ET, Hochberg FH, Pardo FS.

Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):131-7.

PMID:
11516862
17.

Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma.

Rosenberg AE, Nielsen GP, Keel SB, Renard LG, Fitzek MM, Munzenrider JE, Liebsch NJ.

Am J Surg Pathol. 1999 Nov;23(11):1370-8.

PMID:
10555005
18.

Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial.

Fitzek MM, Thornton AF, Rabinov JD, Lev MH, Pardo FS, Munzenrider JE, Okunieff P, Bussière M, Braun I, Hochberg FH, Hedley-Whyte ET, Liebsch NJ, Harsh GR 4th.

J Neurosurg. 1999 Aug;91(2):251-60.

PMID:
10433313
19.

Supplemental Content

Loading ...
Support Center